Adjunctive rufinamide in Lennox-Gastaut syndrome: A long-term, open-label extension study

Acta Neurologica Scandinavica

Volumn 122, Issue 3, 2010, Pages 202-208

  Kluger, G ^a,f   Glauser, T ^b   Krauss, G ^c   Seeruthun, R ^d   Perdomo, C ^e   Arroyo, S ^e  

^a BHZ Vogtareuth ^*  (Germany)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d EISAI CO LTD   (Japan)

^e EISAI INC   (United States)

^f Klinik fur Neuropadiatrie und Neurologische Rehabilitation   (Germany)

Author keywords

epilepsy; extension study; Lennox Gastaut syndrome; open label; rufinamide; tonic atonic seizures; total seizures

Indexed keywords

RUFINAMIDE;

ADOLESCENT; ADULT; AGGRESSION; ANOREXIA; ARTICLE; CHICKENPOX; CHILD; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EPILEPTIC STATE; ESOPHAGITIS; FEMALE; FEVER; GASTRITIS; HEADACHE; HUMAN; LABORATORY TEST; LENNOX GASTAUT SYNDROME; LETHARGY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAL SIGN; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG EVALUATION; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; TREATMENT OUTCOME; TRIAZOLES; YOUNG ADULT;

EID: 77955298453     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01334.x     Document Type: Article

References (18)

1. Arzimanoglou A, French J, Blume WT et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 2009 8 : 82 93.
2. Motte J, Trevathan E, Arvidsson JF et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997 337 : 1807 1812.
3. The Felbamate Study Group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993 328 : 29 33.
4. Sachdeo RC, Glauser TA, Ritter F et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999 52 : 1882 1887.
5. Dodson WE. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia 1993 34 (Suppl. 7 S18 24.
6. Duchowny M, Gilman J, Messenheimer J, Womble G, Risner M, LAMICTAL Pediatric Study Group. Long-term tolerability and efficacy of lamotrigine in pediatric patients with epilepsy. J Child Neurol 2002 17 : 278 285.
7. Glauser TA, Levisohn PM, Ritter F, Sachdeo RC, Topiramate YL Study Group. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000 41 (Suppl. 1 S86 90.
8. Rijckevorsel K. Treatment of Lennox-Gastaut syndrome: overview and recent findings. Neuropsychiatr Dis Treat 2008 4 : 1001 1019.
9. Deeks ED, Scott LJ. Rufinamide. CNS Drugs 2006 20 : 751 760 discussion 761.
10. Arroyo S. Rufinamide. Neurotherapeutics 2007 4 : 155 162.
11. Jain KK. An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development. Expert Opin Investig Drugs 2000 9 : 829 840.
12. White HS, Franklin MR, Kupferberg HJ, Schmutz M, Stables JP, Wolf HH. The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. Epilepsia 2008 49 : 1213 1220.
13. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008 70 : 1950 1958.
14. Ben-Menachem E, Edrich P, Van Vleymen B, Sander JW, Schmidt B. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res 2003 53 : 57 64.
15. Ikeno T, Shigematsu H, Miyakoshi M, Ohba A, Yagi K, Seino M. An analytic study of epileptic falls. Epilepsia 1985 26 : 612 621.
16. Kluger G, Kurlemann G, Haberlandt E et al. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience. Epilepsy Behav 2009 14 : 491 495.
17. Aldenkamp AP, Alpherts WC. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 2006 47 : 1153 1159.
18. Hancock EC, Cross HH. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2009 3 : CD003277.